632356-42-4 Usage
General Description
4-Chloro-3-thiophenamine, also known as 3-Amino-4-chlorothiophene, is an organic compound with the formula C4H4ClNS. It is a heterocyclic amine that contains both a chlorine and a sulfur atom in a five-membered ring. 4-Chloro-3-thiophenamine is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It has potential applications in the production of drugs such as tipepidine and sulconazole. 4-Chloro-3-thiophenamine is also used as an intermediate in the manufacture of dyes, pigments, and other organic compounds. It is important to handle this chemical with caution, as it can be harmful if ingested or inhaled and may cause irritation to the skin and eyes.
Check Digit Verification of cas no
The CAS Registry Mumber 632356-42-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,2,3,5 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 632356-42:
(8*6)+(7*3)+(6*2)+(5*3)+(4*5)+(3*6)+(2*4)+(1*2)=144
144 % 10 = 4
So 632356-42-4 is a valid CAS Registry Number.
632356-42-4Relevant articles and documents
PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY
-
Page/Page column 41, (2016/09/26)
The present invention relates to pyrrolopyridazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
-
Page/Page column 24, (2008/06/13)
Substituted thiophenes, processes for their preparation, their use as medicament or diagnostic agent. The substituted thiophene derivatives have the following backbone structure: Medicaments comprising compounds of this type are of use for preventing or treating various disorders, such as, respiratory disorders and snoring, acute and chronic disorders, disorders induced by ischemic and/or reperfusion events and by proliferative or fibrotic events, disorders of the central nervous system and lipid metabolism, diabetes, blood coagulation and infection by parasites.
